Evidence map›Paper›PMID 41507498›Full record

ArticleEJNMMI radiopharmacy and chemistry2026

Honoka Obata, Atsushi B Tsuji, Yutian Feng, Yongxiang Zheng, Aya Sugyo, Hitomi Sudo, Chie Kajiwara, Katsuyuki Minegishi, Ming-Rong Zhang, Michael R Zalutsky

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Honoka ObataDepartment of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. obata.honoka@qst.go.jp.ORCID http://orcid.org/0000-0002-8408-6416
Atsushi B TsujiDepartment of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Yutian FengDepartment of Radiology, Duke University Medical Center, Durham, NC, 27710, USA.
Yongxiang ZhengDepartment of Radiology, Duke University Medical Center, Durham, NC, 27710, USA.
Aya SugyoDepartment of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Hitomi SudoDepartment of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Chie KajiwaraDepartment of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Katsuyuki MinegishiDepartment of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Ming-Rong ZhangDepartment of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Michael R ZalutskyDepartment of Radiology, Duke University Medical Center, Durham, NC, 27710, USA. michael.zalutsky@duke.edu.

Funding

Japan Science and Technology Agency JPMJAX2223
6 · The paper itself

Abstract

backgroundSeveral platinum radionuclides, including

resultsSix trithiol-Hoechst-PSMA (THP) conjugates that consist of a trithiol ligand for

conclusionsThis study highlighted the importance of the linkers between the three components (trithiol-Hoechst-PSMA) and demonstrated binding of intravenously administered [

Indexed as

Auger electronsBiodistributionPlatinum-191PSMATrithiolTumor DNA binding

Identifiers

PMID41507498
PMCPMC12881198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.